Support of CMC to IND for Novel First-in-Class Small Molecule Drugs
Rapid Proof-of-Concept for Novel Drug Treatment for Rare Metabolic Disease
Proof-of-Concept Efficacy Clinical Study
European Biotechnology Company Seeking First-in-Human U.S. Clinical Study